Molecule Partner With VitaDAO to Create Biopharma IP-to-NFT Transfer Using Nevermined Solution
press release

Molecule Partner With VitaDAO to Create Biopharma IP-to-NFT Transfer Using Nevermined Solution

THELOGICALINDIAN - PRESS RELEASE Molecule a decentralised biopharma exchange has developed a atypical IPtoNFT framework with Web3 technology innovator Nevermined In a celebrated transaction the aboriginal biopharma IPNFT was auspiciously transferred to analysis aggregate VitaDAO to armamentarium atypical constancy analysis at the University of Copenhagen

18th August 2021, Basel, Switzerland — For the aboriginal time in history, NFTs are actuality acclimated for a alteration of IP buying in medical research. This different anniversary is a aftereffect of a affiliation amid biopharma IP exchange Molecule, and VitaDAO, a decentralized aggregate (DAO) allotment constancy research, and the University of Copenhagen. This addition is enabled by a groundbreaking abstracts accumulator band-aid developed by web3 technology innovator Nevermined.

VitaDAO, Nevermined and Molecule Overcome Biopharma Industry Challenges

Early-stage biopharma analysis is the aspect that fuels advances in medicine. However, abounding domains in biopharma ache from abiding underfunding or commercialisation challenges that anticipate addition from extensive patients. Legal complexity, illiquidity of IP assets and abridgement of admission to investors accord to the botheration for researchers.

By applying Web3 technology, Molecule is enabling a apple area advisers get admission to an accessible exchange that makes atypical analysis and IP discoverable, universally fundable and distributes ownership. Nevermined’s abstracts accumulator and admission ascendancy frameworks actualize absolutely new means of how the abstracts rights surrounding this IP can be transacted with and accessed.

VitaDAO afresh became the aboriginal benefactor of this advancement. The aggregate acclimated Molecule’s agreement and IP NFT framework to access IP consistent from constancy analysis run at the Danish Scheibye-Knudsen Lab and transferred buying to VitaDAO.

Molecule CEO Paul Kohlhaas stated:

“This NFT transfers marks a celebrated anniversary for both the NFT and biopharma space. It’s the aboriginal time real-world pharma IP is transacted on a blockchain, while additionally affective into aegis of a DAO.”

Combining Legal Frameworks with Web3 Interoperability

The early-stage analysis appearance is bedeviled by a abnormality coined the Valley of Death – area allotment is adamantine to obtain, acceptation abounding able discoveries never accomplish it to market. Molecule is architecture a exchange for biopharma IP.

A specialised abstruse framework combines acknowledged agreements such as IP licenses with the atypical technology of NFTs and decentralised defended abstracts accumulator networks that are accompanying with the NFT. By ledgering buying rights on Ethereum, Molecule is architecture a exchange for aqueous biopharma analysis abstracts and IP via NFTs. Researchers and biotechs account their projects and discoveries, accept allotment via DeFi and can affix anon with patients. Paul Kohlhaas added:

“IP NFTs could finer alter apparent models and become new amount drivers acknowledgment to Nevermined’s abstracts accumulator frameworks. We achievement to accredit a countless of use cases like this, aboriginal absorption on constancy and brainy bloom and again broadly acceptable a array of “OpenSea” for Biotech NFTs that helps empower new analysis organizations like VitaDAO.”

Simultaneously, new cartage to coact and armamentarium analysis are basic in the web3 space. VitaDAO is a “Decentralised Autonomous Organisation” that collectively funds aboriginal constancy analysis projects via its association contributors. In June 2024, it aloft $5 actor from hundreds of individuals via a Gnosis accumulation bargain – agreement the organisation anon into the easily of its community. Now it is on a mission to accounts the best able constancy analysis endeavours and decentralise their ownership.

Want to Live Forever? There’s an NFT for That

The circuitous requirements for storing, appointment and accessing IP-related files crave added than aloof a accepted NFT. Nevermined implemented its Admission Ascendancy bore to actualize NFTs on steroids with Molecule. These atypical NFTs accredit the transacting parties to appoint with the basal adequate analysis abstracts via amalgamated admission control. This use case has a advanced ambit of applications in the biologic industry.

Nevermind CTO Aitor Argomániz stated:

“Access Control allows creators and owners of agenda assets to attach altitude to an NFT. Think of things like pricing, absolute users, aloofness parameters, etc.. At the aforementioned time, it acts as a Gateway to agreement that alone parties that accomplish assertive altitude can get admission to the basal documents.”

The bore is additionally cross-tech-compatible. This allows apps to accomplish secure, analytical access amid Ethereum, the billow (e.g AWS) and decentralised hosting (e.g Arweave). This is the alone way to agreement a Certificate of Authenticity with permanence, traceability and aloofness built-in..

 

Nevermined Socials

Medium | Discord | Twitter

 

Molecule Socials

Medium | Telegram | Twitter | Discord

 

VitaDao Socials

Medium | Telegram | Twitter | Discord

 

Media Contact Details

Contact Name: Oana Ionescu

Contact Email: [email protected]

 

Molecule is the antecedent of this content. This Press Release is for advisory purposes only. The admonition does not aggregate advance admonition or an action to invest.

This is a columnist release. Readers should do their own due activity afore demography any accomplishments accompanying to the answer aggregation or any of its affiliates or services. Bitcoin.com is not responsible, anon or indirectly, for any accident or accident acquired or declared to be acquired by or in affiliation with the use of or assurance on any content, appurtenances or casework mentioned in the columnist release.

Image Credits: Shutterstock, Pixabay, Wiki Commons